Lipogems is a clinical-stage, global medical technology company that utilizes autologous adipose tissue for therapeutic use in orthopaedics and other specialties. Its core product is a minimally invasive, one-time procedure performed in a sterile outpatient or operating-room setting in about 40 minutes. Independent, investigator-initiated studies have shown the procedure can improve pain, function and quality of life for patients with knee osteoarthritis. The company’s products are used across orthopaedics, general surgery, and plastic and reconstructive surgery and are available in 29 countries. Lipogems is based in Atlanta, GA. The company recently raised €12.5M in growth funding to support ongoing clinical work.

Total raised

$13M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2022